ArticleAntiviral research2023

CDK4/6 inhibitor palbociclib promotes SARS-CoV-2 cell entry by down-regulating SKP2 dependent ACE2 degradation.

Yingzi Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.